First Affiliated Hospital Of Zhejiang University
Clinical trials sponsored by First Affiliated Hospital Of Zhejiang University, explained in plain language.
-
Could a "Shock and kill" strategy finally eradicate hidden HIV?
Disease control Not yet recruitingThis early-stage trial tests a two-step approach to target hidden HIV. First, a drug called chidamide wakes up dormant HIV hiding in cells. Then, specially designed natural killer (NK) cells are infused to find and destroy those infected cells. The study enrolls 20 adults with we…
Phase: PHASE1, PHASE2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated May 26, 2026 03:30 UTC
-
New drug iptacopan offers hope for rare transplant complication
Disease control Not yet recruitingThis study tests a pill called iptacopan for people who develop a serious blood vessel condition (TA-TMA) after a stem cell transplant. The drug aims to block harmful immune activity and improve survival. About 30 participants will take the pill and be monitored for up to 2 years…
Phase: NA • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated May 26, 2026 03:16 UTC
-
New combo procedure aims to fix aortic tears for good
Disease control Not yet recruitingThis study tests a new way to treat a serious tear in the main artery (type B aortic dissection). The standard procedure uses a stent-graft to close the main tear, but blood can still leak through smaller tears, causing the artery to widen and need more procedures. This study add…
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New hope for tough lymphoma: drug cocktail targets resistant cancer
Disease control Not yet recruitingThis study tests a new combination of drugs (homoharringtonine, a BCL-2 inhibitor, rituximab, and prednisone) in adults whose diffuse large B-cell lymphoma has come back or not responded to standard treatment. The goal is to find the safest dose and see if the combination shrinks…
Phase: PHASE1, PHASE2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated May 18, 2026 12:03 UTC
-
New hope for brain stem bleeding: minimally invasive surgery tested in major trial
Disease control Not yet recruitingThis study tests if a precise, minimally invasive surgery (stereotactic aspiration) can improve outcomes for people with severe brain stem bleeding compared to standard medical care. The trial will enroll 300 adults with large hematomas and severe symptoms. The main goal is to se…
Phase: NA • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New scan could spot lung cancer more accurately
Diagnosis Not yet recruitingThis study will test a new type of PET/CT scan called 18F-FAPI to see how well it can find lung cancer and predict patient outcomes. About 120 people with lung cancer will get this scan. The goal is to improve diagnosis and help doctors make better treatment decisions.
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Diagnosis
Last updated May 26, 2026 03:28 UTC
-
New PET scan could solve the mystery of hidden cancers
Diagnosis Not yet recruitingThis study will test a special type of PET scan (18F-FAPI PET/CT) in 120 people whose cancer started from an unknown location. The goal is to see if this scan can better find where the cancer began, help doctors choose the right treatment, and predict outcomes. Participants will …
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Diagnosis
Last updated May 26, 2026 03:16 UTC
-
New scan duo could spot stomach cancer more accurately
Diagnosis Not yet recruitingThis study aims to see if combining a special PET scan (18F-FAPI) with detailed MRI can improve how doctors diagnose and predict outcomes for gastric cancer. About 230 people with suspected or confirmed gastric cancer will receive both scans. The goal is to measure how accurate t…
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Diagnosis
Last updated May 26, 2026 03:15 UTC
-
New PET scan could sharpen detection of rare tumors
Diagnosis Not yet recruitingThis study will see if a special PET scan (18F-Octreotide) can more accurately find neuroendocrine tumors, help doctors plan treatment, and predict how the disease will progress. About 152 adults who have or are suspected of having these tumors will get the scan. The goal is to i…
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Diagnosis
Last updated May 26, 2026 03:04 UTC
-
Gut bacteria may lift mood: new probiotic trial for depression
Symptom relief Not yet recruitingThis study tests whether a probiotic called Bifidobacterium PB-18 can help adults with mild to moderate depression. Participants will take either the probiotic or a placebo daily for 8 weeks, and researchers will track mood changes and side effects. The goal is to see if improvin…
Phase: NA • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Symptom relief
Last updated May 26, 2026 03:24 UTC
-
Seaweed and fiber cocktail tested as natural sleep aid
Symptom relief Not yet recruitingThis study tests whether taking inulin (a fiber) and spirulina (a type of algae) can improve sleep in adults aged 18 to 60 with chronic insomnia. 180 participants will be split into four groups: inulin alone, spirulina alone, both together, or a placebo. They will take the supple…
Phase: NA • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Symptom relief
Last updated May 26, 2026 03:04 UTC
-
Brain zaps to sharpen bipolar minds: new trial launches
Symptom relief Not yet recruitingThis study tests a noninvasive brain stimulation technique called transcranial magnetic stimulation (TMS) to see if it can improve memory and thinking in people with bipolar disorder. Researchers will enroll 88 adults with stable bipolar disorder and give them either real or fake…
Phase: NA • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Symptom relief
Last updated May 18, 2026 12:03 UTC
-
Brain wave study seeks to unlock secrets of anesthesia
Knowledge-focused Not yet recruitingThis study looks at brain wave patterns in 48 adults having arm or leg surgery under nerve blocks and sedation. Researchers want to understand how the brain behaves when a person is unconscious from anesthesia and when they wake up. The goal is to learn more about sedation depth …
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Knowledge-focused
Last updated May 26, 2026 03:29 UTC
-
Morning vs. evening shots: which boosts stem cell donation?
Knowledge-focused Not yet recruitingThis study looks at whether giving a daily G-CSF shot in the morning or evening helps healthy stem cell donors produce more cells for transplant. About 160 donors will get the shot at either 8 AM or 8 PM for five days. The goal is to find a simple schedule that works best for col…
Phase: NA • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Knowledge-focused
Last updated May 26, 2026 03:15 UTC
-
Which lung setting is safest during surgery? new study aims to find out.
Knowledge-focused Not yet recruitingThis study looks at different breathing machine settings used during lung surgery (VATS) to find which one causes the fewest lung problems after surgery. About 650 adults over age 50 having lung cancer surgery will take part. The goal is to find the best way to protect the lungs …
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Knowledge-focused
Last updated May 22, 2026 13:50 UTC
-
New study tracks patient discomfort after aortic surgery
Knowledge-focused Not yet recruitingThis study will observe 132 people who had a procedure to fix a tear or bulge in their main artery (aorta). The goal is to measure different types of discomfort they may feel afterward, such as back pain, skin irritation from bandages, trouble moving, and stress. The results will…
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Knowledge-focused
Last updated May 18, 2026 12:01 UTC
-
A randomized, double-blind, placebo-controlled, prospective, multi-center trial evaluating the improvement of nutritional status and sarcopenia with silkworm pupa tablets in patients with malignancies
Not yet recruitingThis is a randomized, double-blind, placebo-controlled, parallel-group, prospective, multi-center clinical trial, to evaluate the efficacy of silkworm pupa tablets in improving nutritional status and sarcopenia in patients with malignancies who have completed comprehensive treatm…
Phase: PHASE3 • Sponsor: First Affiliated Hospital of Zhejiang University
Last updated May 11, 2026 20:49 UTC